Published in Adv Exp Med Biol on January 01, 1984
Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol (2001) 1.85
Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol (2000) 1.80
An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues. J Neurochem (1987) 1.66
Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci U S A (1998) 1.51
Nerve growth factor-induced fiber outgrowth from isolated rat adrenal chromaffin cells: impairment by glucocorticoids. Proc Natl Acad Sci U S A (1978) 1.50
Nerve growth factor gene expression in the developing rat brain. Science (1986) 1.41
Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci U S A (1993) 1.33
Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J Autoimmun (2000) 1.32
Nerve growth factor (NGF) in the rat CNS: absence of specific retrograde axonal transport and tyrosine hydroxylase induction in locus coeruleus and substantia nigra. Brain Res (1979) 1.28
Nerve growth factor-mediated selective induction of ornithine decarboxylase in rat pheochromocytoma; a cyclic AMP-independent process. FEBS Lett (1978) 1.19
Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid. Neurosci Lett (1992) 1.19
Inflammatory signals induce neurotrophin expression in human microglial cells. J Neurochem (1998) 1.18
Dopamine, norepinephrine and serotonin production by an intestinal carcinoid tumor. Cancer (1980) 1.16
Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression. Glia (1999) 1.12
Neural activities of IL-6-type cytokines often depend on soluble cytokine receptors. Eur J Neurosci (1999) 1.11
Gangliosides in nervous tissue cultures and binding of 125I-labelled tetanus toxin, a neuronal marker. J Neurochem (1977) 1.08
Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res (1994) 1.05
Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci Lett (1990) 1.05
Selective induction of tyrosine hydroxylase and dopamine beta-hydroxylase by nerve growth factor: comparison between adrenal medulla and sympathetic ganglia of adult and newborn rats. Brain Res (1977) 1.04
Increased levels of NGF in sera of systemic lupus erythematosus patients. Neuroreport (1993) 1.03
Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol (1994) 1.01
Requirement of nerve growth factor for development of substance P-containing sensory neurones. Nature (1980) 0.98
Nerve growth factor induces mast cell degranulation without changing intracellular calcium levels. FEBS Lett (1986) 0.97
Biochemical effects of antibodies against nerve growth factor on developing and differentiated sympathetic ganglia. Brain Res (1978) 0.96
Anti-inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: inhibition of monocyte transendothelial migration. Eur J Immunol (2001) 0.96
Biochemical and anatomical effects of antibodies against nerve growth factor on developing rat sensory ganglia. Proc Natl Acad Sci U S A (1984) 0.95
Developmental regulation of nerve growth factor and its receptor in the rat caudate-putamen. Neuron (1989) 0.95
Expression of functional trk protooncogene in human monocytes. Proc Natl Acad Sci U S A (1993) 0.95
Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease. Neurosci Lett (1998) 0.94
Effect of glucocorticoids on nerve growth factor-mediated enzyme induction in organ cultures of rat sympathetic ganglia: enchanced response and reduced time requirement to initiate enzyme induction. J Neurochem (1977) 0.94
Shape changes induced by biologically active peptides and nerve growth factor in blood platelets of rabbits. Br J Pharmacol (1981) 0.94
Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci Lett (1994) 0.93
NF-kappaB modulates lipopolysaccharide-induced microglial nerve growth factor expression. Glia (1998) 0.93
Effect of the external nasal dilator Breathe Right on snoring. Eur J Med Res (1998) 0.91
Nerve conduction changes and fine structural alterations of extra- and intrafusal muscle and nerve fibers in streptozotocin diabetic rats. Muscle Nerve (1995) 0.91
Expression of functional trk tyrosine kinase receptors after T cell activation. J Immunol (1994) 0.91
Interleukin-6 (IL-6) and its soluble receptor support survival of sensory neurons. J Neurosci Res (1999) 0.90
Stimulation of the pituitary-adrenocortical axis by nerve growth factor. Nature (1979) 0.89
Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors. Neurosci Lett (1997) 0.89
Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett (1997) 0.89
GABA(B) receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats. Neuropharmacology (2000) 0.89
Increased levels of nerve growth factor (NGF) protein and mRNA and reactive gliosis following kainic acid injection into the rat striatum. Neurosci Lett (1994) 0.88
The influence of electromagnetic fields on human brain activity. Eur J Med Res (1995) 0.87
Nerve growth factor antagonizes the neurotoxic action of capsaicin on primary sensory neurones. Nature (1983) 0.87
Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression. Mol Psychiatry (2000) 0.87
Binding characteristics of 125I-labelled tetanus toxin to primary tissue cultures from mouse embryonic CNS. J Neurochem (1977) 0.86
Epidermal growth factor content of submandibular glands is increased in rats with experimentally induced gastric lesions. Scand J Gastroenterol (1988) 0.86
Location of an isoproterenol-responsive cyclic AMP pool in adrenergic nerve cell bodies and its relationship to tyrosine 3-monooxygenase induction. Proc Natl Acad Sci U S A (1974) 0.86
Beta-amyloid modulates tyrosine kinase B receptor expression in SHSY5Y neuroblastoma cells: influence of the antioxidant melatonin. Neuroscience (2003) 0.86
Modulatory role of glucocorticoids on NGF-mediated enzyme induction in organ cultures of sympathetic ganglia. Brain Res (1976) 0.86
Heterogeneity of human neuroblastoma cell lines in their proliferative responses to basic FGF, NGF, and EGF: correlation with expression of growth factors and growth factor receptors. J Neurosci Res (1995) 0.86
Selective induction of tyrosine hydroxylase and dopamine beta-hydroxylase in sympathetic ganglia in organ culture: role of glucocorticoids as modulators. Mol Pharmacol (1976) 0.86
Nerve growth factor-mediated induction of tyrosine hydroxylase in rat superior cervical ganglia in vitro. J Biol Chem (1978) 0.86
Suppression of 3H-acetylcholine release from primary nerve cell cultures by tetanus and botulinum-A toxin. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.85
Expression of interleukin-6 receptor (IL-6R) and gp130 mRNA in PC12 cells and sympathetic neurons: modulation by tumor necrosis factor alpha (TNF-alpha). Brain Res (1996) 0.85
Quantitative EEG and BPRS data following Haldol-Decanoate administration in schizophrenics. Int Clin Psychopharmacol (1994) 0.85
Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation. Eur J Neurosci (1997) 0.85
GABA(B) receptor expression and cellular localization in gerbil hippocampus after transient global ischemia. Neurosci Lett (2005) 0.84
Differential expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat hypothalamus. Neurosci Lett (1993) 0.84
Relationship between the rate of axoplasmic transport and subcellular distribution of enzymes involved in the synthesis of norepinephrine. J Neurochem (1973) 0.84
Nerve growth factor (NGF) regulates tachykinin gene expression and biosynthesis in rat sensory neurons during early postnatal development. Neuropeptides (1993) 0.84
Nerve growth factor induces plasma extravasation in rat skin. Eur J Pharmacol (1984) 0.84
Alterations in trk A, trk B and trk C receptor immunoreactivities in parietal cortex and cerebellum in Alzheimer's disease. Eur Neurol (2000) 0.83
Increased CSF levels of nerve growth factor in patients with Alzheimer's disease. Neurology (2000) 0.83
Nerve growth factor as a mediator of information between effector organs and innervating neurons. Symp Soc Dev Biol (1978) 0.83
Immunization of adult rats against 2.5 S NGF: effects on the peripheral sympathetic nervous system. Brain Res (1979) 0.83
Effects of antibodies against nerve growth factor on the postnatal development of substance P-containing sensory neurons. Neurosci Lett (1982) 0.82
Age-dependent time course of cerebral brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 in APP23 transgenic mice. J Neurosci Res (2008) 0.82
Nerve growth factor expression in the developing hippocampus isolated in vitro. Dev Biol (1990) 0.82
Organ culture of the rat adrenal medulla: a model system for the study of trans-synaptic enzyme induction. J Neurochem (1975) 0.81
Alterations in neurotrophins and neurotrophin receptors in Alzheimer's disease. J Neural Transm Suppl (2000) 0.81
Mechanisms of tyrosine hydroxylase and dopamine beta-hydroxylase induction in organ cultures of rat sympathetic ganglia by potassium depolarization and cholinomimetics. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.81
Interaction of labelled tetanus toxin with substructures of rat spinal cord in vivo. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.81
Biosynthesis and release of tachykinins from rat sensory neurons in culture. J Neurosci Res (1991) 0.81
Immunosympathectomy: lack of evidence for a complement-mediated cytotoxic mechanism. Brain Res (1980) 0.81
Hyperexcitability of cultured central nervous system neurons caused by tetanus toxin. Exp Neurol (1979) 0.81
Circadian rhythm of tyrosine hydroxylase induction by short-term cold stress: modulatory action of glucocorticoids in newborn and adult rats. Proc Natl Acad Sci U S A (1975) 0.81
Relation between psychometric tests and quantitative topographic EEG in pharmacology. Int J Clin Pharmacol Ther Toxicol (1992) 0.81
125I-Labelled tetanus toxin as a neuronal marker in tissue cultures derived from embryonic CNS. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.81
Pharmacodynamic effects of valerian and hops extract combination (Ze 91019) on the quantitative-topographical EEG in healthy volunteers. Eur J Med Res (2000) 0.80
Radioelectroencephalography (Tele-Stereo-EEG) in the rat as a pharmacological model to differentiate the central action of flupirtine from that of opiates, diazepam and phenobarbital. Neuropsychobiology (1986) 0.80
Postnatal expression of interleukin-6 (IL-6) and IL-6 receptor (IL-6R) mRNAs in rat sympathetic and sensory ganglia. Brain Res (1996) 0.80
Multiunit activity from the A9 and A10 areas in rats following chronic treatment with different neuroleptic drugs. Eur Neuropsychopharmacol (1994) 0.80
Reflection of mental exercise in the dynamic quantitative topographical EEG. Neuropsychobiology (1995) 0.80
Neurotrophin expression modulated by glucocorticoids and oestrogen in immortalized hippocampal neurons. Brain Res Mol Brain Res (1995) 0.80
Classification of drugs by stereotactic recording of focal brain activity in the rat (stereo-EEG). Neuropsychobiology (1984) 0.80
Biological importance of the retrograde axonal transport of nerve growth factor in sensory neurons. Proc Natl Acad Sci U S A (1981) 0.80
Fimbria-fornix lesion increases nerve growth factor content in adult rat septum and hippocampus. Neurosci Lett (1986) 0.80
Effect of gangliosides on nerve conduction velocity during diabetic neuropathy in the rat. Arch Int Pharmacodyn Ther (1987) 0.79
Permissive action of glucocorticoids in induction of tyrosine hydroxylase by nerve growth factor in a pheochromocytoma cell line. Brain Res (1980) 0.79
Correlation between substance P content of primary sensory neurones and pain sensitivity in rats exposed to antibodies to nerve growth factor. Eur J Pharmacol (1982) 0.79
Nerve growth factor from the venom of the Chinese cobra Naja naja atra: purification and description of non-neuronal activities. Toxicon (1995) 0.79
Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor synthesis in rat mesangial cells. Am J Physiol (1991) 0.79
Pathophysiology and psychopharmacology of dementia--a new study design. I. Diagnosis comprising subjective and objective criteria. Neuropsychobiology (1995) 0.78
The role of sodium influx mediated by nicotinic receptors as an initial event in trans-synaptic induction of tyrosine hydroxylase in adrenergic neurons. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.78
Effects of perinatal hypo- and hyperthyroidism on the levels of nerve growth factor and its low-affinity receptor in cerebellum. Brain Res Dev Brain Res (1993) 0.78
Proteolytic cleavage of inducible nitric oxide synthase (iNOS) by calpain I. Biochim Biophys Acta (2001) 0.78
Expression of GABA(A) receptors by reactive astrocytes in explant and primary cultures of rat CNS. Int J Dev Neurosci (1997) 0.78
On the role of RNA synthesis in the selective induction of tyrosine hydroxylase by nerve growth factor. Brain Res (1978) 0.78